Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

IDX/HEAL stock hub

IDX/HEAL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/HEALis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.2T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/HEAL

In the news

Latest news · IDX/HEAL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.1

P25 9.4P50 14.4P75 23.9

Trailing P/E37.1

P25 11.5P50 23.8P75 52.6

ROE7.8

P25 0.6P50 5.1P75 12.2

ROIC6.9

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/HEAL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

IDR

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	18,636
Employees Change	1,010%
Employees Change Percent	5.73
Enterprise value	IDR 19.5T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	ID1000143100
Last refreshed	2026-05-10
Market cap	IDR 15.2T
Price	IDR 995
Price currency	IDR
Rev Per Employee	384,576,683.52x
Sector	Healthcare
Sic	8062
Symbol	idx/HEAL
Website	https://www.herminahospitals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.66%
EV Earnings	47.9x
EV/EBIT	20.97x
EV/EBITDA	10.04x
EV/FCF	-39.15x
EV/Sales	2.69x
FCF yield	-3.26%
Forward P/E	29.05x
P/B ratio	2.09x
P/E ratio	37.05x
P/S ratio	2.11x
PE Ratio10 Y	45.32x
PE Ratio3 Y	46.11x
PE Ratio5 Y	42.61x
PEG ratio	2.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.84%
EBITDA Margin	26.76%
Gross margin	31.51%
Gross Profit	IDR 2.3T
Gross Profit Growth	0.42%
Gross Profit Growth Q	-0.79%
Gross Profit Growth3 Y	13.09%
Gross Profit Growth5 Y	-0.76%
Net Income	IDR 406.1B
Net Income Growth	-13.55%
Net Income Growth Q	-18.81%
Net Income Growth Years	0%
Net Income Growth3 Y	11.08%
Net Income Growth5 Y	-9.92%
Pretax Margin	9.84%
Profit Margin	5.62%
Profit Per Employee	IDR 21.6M
Profitable Years	11
ROA	5.06
Roa5y	7.83
ROCE	9.02
ROE	7.83
Roe5y	14.7
ROIC	6.92
Roic5y	13.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-18.45%
Cagr3y	-8.81%
Cagr5y	2.8%
Div CAGR3	24.47%
Div CAGR5	21.98%
EPS Growth	-14.22
EPS Growth Q	-18.74
EPS Growth Years	0
EPS Growth3 Y	10.06
EPS Growth5 Y	-10.25
OCF Growth	12.48%
OCF Growth Q	10.86%
OCF Growth3 Y	3.62%
OCF Growth5 Y	8.4%
Revenue Growth	7.77x
Revenue Growth Q	5.36x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	12.71x
Revenue Growth5 Y	7.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.63
Assets	IDR 12.1T
Cash	IDR 844.6B
Current Assets	IDR 2.4T
Current Liabilities	IDR 1.8T
Debt	IDR 3.5T
Debt EBITDA	IDR 1.8
Debt Equity	IDR 0.48
Debt FCF	IDR -7.04
Equity	IDR 7.3T
Interest Coverage	3.89
Liabilities	IDR 4.8T
Long Term Assets	IDR 9.6T
Long Term Liabilities	IDR 3T
Net Cash	IDR -2.7T
Net Cash By Market Cap	IDR -17.4
Net Debt EBITDA	IDR 1.37
Net Debt Equity	IDR 0.36
Tangible Book Value	IDR 5.7T
Tangible Book Value Per Share	IDR 372
WACC	3.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.36
Inventory Turnover	33.56
Net Working Capital	IDR 396B
Quick ratio	1.25
Working Capital	IDR 652.8B
Working Capital Turnover	IDR 16.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.8%
Dividend Growth	28.57%
Dividend Growth Years	7%
Dividend per share	IDR 10.5
Dividend Years	8
Dividend Yield	1.06%
Ex Div Date	2026-05-05
Last Dividend	IDR 13.5
Payout Frequency	Annual
Payout Ratio	38.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-18.44%
200-day SMA	1,444.5
3Y total return	-24.17%
50-day SMA	1,232.1
50-day SMA vs 200-day SMA	50under200
5Y total return	14.79%
All Time High	1,800
All Time High Change	-44.72%
All Time High Date	2023-01-09
All Time Low	370
All Time Low Change	168.92%
All Time Low Date	2020-03-24
ATR	51.84
Beta	-0.12
Beta1y	-0.06
Beta2y	0.23
Ch YTD	-27.64
High	1,035
High52	1,775
High52 Date	2025-08-20
High52ch	-43.94%
Low	990
Low52	990
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-19.24%
Price vs 200-day SMA	-31.12%
RSI	18.65
RSI Monthly	37.03
RSI Weekly	22.03
Sharpe ratio	0.08x
Sortino ratio	0.3
Total Return	0.26%
Tr YTD	-26.75
Tr1m	-17.1%
Tr1w	-9.26%
Tr3m	-21.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 927.5B
Operating Income Growth	-6.4
Operating Income Growth Q	-15.51
Operating Income Growth3 Y	17.42
Operating Income Growth5 Y	-7.77
Operating margin	12.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,141,334,096%
Net Borrowing	164,517,000,000
Shares Insiders	26.61%
Shares Institutions	5.85%
Shares Out	15,319,034,300
Shares Qo Q	-0.11%
Shares Yo Y	0.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR -496.8B
Average Volume	9,321,935x
Bv Per Share	373.2
CAPEX	IDR -1.7T
Ch1m	-18.11
Ch1w	-10.36
Ch1y	-19.43
Ch3m	-22.87
Ch3y	-26.57
Ch5y	10.07
Ch6m	-32.77
Change	-2.93%
Change From Open	-2.93
Close	1,025
Days Gap	0
Depreciation Amortization	1,005,622,000,000
Dollar Volume	14,543,716,000
Earnings Date	2026-07-31
EBIT	IDR 927.5B
EBITDA	IDR 1.9T
EPS	IDR 26.86
F Score	5
FCF	IDR -496.8B
FCF EV Yield	-2.55x
FCF Per Share	IDR -32.43
Financing CF	859,797,000,000
Fiscal Year End	December
Founded	1,985
Graham Number	474.87239
Graham Upside	-52.27
Income Tax	IDR 190.3B
Investing CF	-1,757,478,000,000
Is Primary Listing	1
Last Earnings Date	2025-10-30
Last Report Date	2026-03-31
Last Split Date	2021-07-30
Last Split Type	Forward
Lynch Fair Value	IDR 134
Lynch Upside	-86.5
Ma150	1,377.6
Ma150ch	-27.77%
Ma20	1,158.5
Ma20ch	-14.11%
Net CF	264,522,000,000
Next Earnings Date	2026-07-31
Open	1,025
P OCF Ratio	13.12
Payment Date	2026-05-22
Position In Range	11.11
Ppne	8,350,007,000,000
Price Date	2026-05-08
Price EBITDA	IDR 7.88
Ptbv Ratio	2.68
Relative Volume	1.67x
Revenue	7,224,273,000,000x
Tax By Revenue	2.63x
Tax Rate	26.77%
Tr6m	-31.94%
Volume	14,616,800
Z Score	4.03

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IDX/HEAL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$10.5 annual per share

Payout ratio

+38.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+22.0%

7 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2026-05-05

Performance

IDX/HEAL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/HEAL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.9%

Share of float held by funds and institutions

Insider ownership

+26.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

IDX/HEAL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

18.6

Below 30: short-term oversold

Price vs 200-day MA

-31.1%

50/200-day relationship not available

Beta (5Y)

-0.12

Less volatile than the market

Sharpe ratio

0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/HEAL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/HEAL stock rating?

idx/HEAL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/HEAL analysis?

The full report lives at /stocks/idx/HEAL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/HEAL?

The latest report frames idx/HEAL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/HEAL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.